Morphine-induced trafficking of a mu-opioid receptor interacting protein in rat locus coeruleus neurons

Kellie M Jaremko1, Nicholas L Thompson1, Beverly A S Reyes1

  • 1Department of Pharmacology and Physiology, Drexel University College of Medicine, Philadelphia, PA 19102, United States.

Insights

Opiate addiction affects millions. Researchers found that Wntless (WLS) protein trafficking to the cell membrane in the locus coeruleus (LC) is altered by morphine and heroin, suggesting a role in opiate addiction.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Addiction Research

Background:

  • Opiate addiction is a significant public health issue, impacting millions globally.
  • Cellular adaptations in neurons, particularly at the mu opioid receptor (MOR), occur following opioid exposure.
  • Wntless (WLS), a protein involved in Wnt protein secretion, is a potential regulator of MOR trafficking.

Purpose of the Study:

  • To investigate the anatomical distribution of WLS and MOR in the rat locus coeruleus (LC)-norepinephrine (NE) system.
  • To determine if WLS and MOR co-localize in LC neurons.
  • To examine the effect of morphine and heroin on WLS distribution and MOR-WLS association in the LC.

Main Methods:

  • Dual immunofluorescence microscopy was employed to visualize WLS and MOR localization in rat LC.
  • Rats were treated with saline, morphine, or DAMGO, and LC tissues were analyzed using immunogold-silver detection.
  • Co-immunoprecipitation studies were performed on brain tissue from saline- or heroin-treated rats.

Main Results:

  • Morphine treatment induced a redistribution of WLS to the plasma membrane in LC neurons and increased MOR-WLS proximity.
  • DAMGO treatment resulted in WLS and MOR primarily localizing to the cytoplasmic compartment.
  • Heroin self-administration led to an increased association between WLS and MOR in the LC.

Conclusions:

  • WLS is localized to noradrenergic neurons in the rat LC and co-exists with MOR.
  • Opiate exposure, including morphine and heroin, significantly alters WLS trafficking and MOR-WLS interactions within the LC.
  • These adaptations in WLS may modulate MOR function in the LC, potentially contributing to the cognitive deficits associated with opiate addiction.

Related Concept Videos

Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
7.2K
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
3.3K
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
1.7K
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.5K
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.6K
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.8K